Percutaneously Delivered Automated Continual Fluid Removal System in Patients With Advanced Diuretic-Resistant Heart Failure
NCT:NCT06689553 · TERMINATED
廣告
NCT IDNCT06689553
狀態TERMINATED
開始日期2025-09-28
完成時間2026-05-05
SponsorParagate Medical LTD (INDUSTRY)
First posted
Last updated
簡要摘要
The study aims to assess the feasibility, safety, tolerability and functionality of a percutaneously delivered automated continual fluid removal System in up to 8 patients with Heart Failure (HF) and diuretic resistance. Intervention: Implanted absorption chamber, connected to an external pump. Follow up: 6 months post activation.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。